CAIX-targeted imaging may improve clear cell RCC staging
Review · Renal & Urology News · 2026-10-07. Number 3 in the UrologyWatch Top 5 for October 8, 2026.
A news report states that imaging agents targeting carbonic anhydrase IX (CAIX), a marker enriched in clear cell renal cell carcinoma, may improve staging accuracy. The source provides only a headline, with no study details, design, or data available for verification.
Why it matters: If confirmed by full study data, CAIX-targeted imaging could aid staging and surgical planning for clear cell RCC, pending prospective validation.
Source: Renal & Urology News
Loading today's edition…